{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:16:07Z","timestamp":1766268967501,"version":"3.46.0"},"reference-count":0,"publisher":"Touch Medical Media, Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p>Denosumab is a monoclonal antibody which is currently licensed in the UK drug market for the prevention of skeletal-related events secondary to malignancy (excluding myeloma). This monoclonal antibody is a 6 monthly subcutaneous injection that works by lowering calcium levels. When used in a 90 year old patient with primary hyperparathyroidism it demonstrated a dramatic reduction in the calcium level which had proven difficult to reduce by bisphosphonates and who was not a candidate for surgical intervention.<\/jats:p>","DOI":"10.17925\/ee.2014.10.02.151","type":"journal-article","created":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T05:59:30Z","timestamp":1434779970000},"page":"151","source":"Crossref","is-referenced-by-count":4,"title":["The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism"],"prefix":"10.17925","volume":"10","author":[{"given":"Tamer","family":"Shalaby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Anandappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva","family":"Sivappriyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Registrar in Acute Medicine and Endocrinology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"CT1 Endocrinology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Consultant Endocrinologist, Maidstone Hospital, Maidstone, Kent, UK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Consultant Endocrinologist, Maidstone Hospital, Maidstone, Kent, UK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7274","container-title":["European Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/touchendocrinology.com\/thyroid\/journal-articles\/the-use-of-denosumab-in-a-nonagenarian-with-primary-hyperparathyroidism\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:00:46Z","timestamp":1764745246000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.touchendocrinology.com\/articles\/use-denosumab-nonagenarian-primary-hyperparathyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["EE.2014.10.02.151"],"URL":"https:\/\/doi.org\/10.17925\/ee.2014.10.02.151","relation":{},"ISSN":["1758-3772"],"issn-type":[{"type":"print","value":"1758-3772"}],"subject":[],"published":{"date-parts":[[2014]]}}}